We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tigris Trial Enrollment at 135 PatientsStrengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc...
• 135 patients enrolled TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options...
• 132 patients enrolled TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic...
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Tigris Trial Enrollment Reaches 126 Patients Strengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc...
This Phase 3 company is seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, and shares are moving up. Late-stage theranostic company Spectral To read...
• 125 patients enrolled• Record July patient enrollment to start the second half of 2024 TORONTO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY...
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
116 patients enrolledJune represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -1.72413793103 | 0.58 | 0.62 | 0.52 | 142706 | 0.55341476 | CS |
4 | 0 | 0 | 0.57 | 0.62 | 0.52 | 75362 | 0.5747963 | CS |
12 | -0.09 | -13.6363636364 | 0.66 | 0.71 | 0.52 | 77188 | 0.60584012 | CS |
26 | 0.08 | 16.3265306122 | 0.49 | 0.75 | 0.46 | 74200 | 0.57646908 | CS |
52 | 0.23 | 67.6470588235 | 0.34 | 0.75 | 0.32 | 75970 | 0.53829631 | CS |
156 | 0.305 | 115.094339623 | 0.265 | 0.75 | 0.15 | 69187 | 0.40976086 | CS |
260 | -0.08 | -12.3076923077 | 0.65 | 0.85 | 0.15 | 79416 | 0.45980719 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions